A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dale R Shepard, MD, PhD
The Cleveland Clinic
Principal Investigator - Esra E Cohen, MD
University of California, San Diego
Principal Investigator - Pfizer CT.gov Call Center
Pfizer
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uc San Diego Medical Center - la Jolla(thornton Hospital)
La Jolla, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- University of California / San Diego Moores Cancer Center
La Jolla, California, United States
- University of California San Diego Moores Cancer Center
La Jolla, California, United States
- Uc San Diego Medical Center - Hillcrest
San Diego, California, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Henry Ford Hospital Research Pharmacy
Detroit, Michigan, United States
- Unc Cancer Hospital Infusion Pharmacy
Chapel Hill, North Carolina, United States
- Unc Hospitals, University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio, United States
- Sanford Cancer Center
Sioux Falls, South Dakota, United States
- Sanford Research
Sioux Falls, South Dakota, United States
- Sanford Usd Medical Center
Sioux Falls, South Dakota, United States
- Tennessee Oncology, Pllc
Gallatin, Tennessee, United States
- Tennessee Oncology, Pllc
Nashville, Tennessee, United States
- the Sarah Cannon Research Institute
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2015
- Primary completion
- 30 Sept 2017
- Completion
- 31 Oct 2017
- Last update posted
- 27 Feb 2019
- Registered enrollment
- 24
- Registry id
- NCT02444793
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.